Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: READE SMITH who wrote (770)	4/2/1998 6:33:00 AM
From: Mark Bartlett	Read Replies (1) \| Respond to of 14101

READE, <<I have a conspiracy theory to account for the long delays in Pennsaid approval.>> I have thought of the same thing .... I would like to hold my fellow man above that type of behaviour ... but when it comes to big $$$, I am cynical. Considering both of the main components of the medication have been around for years, and they have gone through such extensive testing with next to no side effects, the approval process should not be particularly arduous. That being said, the average time for a drug approval in Canada is in the area of 17 months, we have not yet gone passed that yet. However, if we go too much passed that, I will not be happy about it. Also - DMX paid a rather hefty fee to have the drug evaluated through Health Canada ... just the same as the majors. Let's give it some more time - then we can consider some options. MB